ALDH1A3 and cancer: It has been reported that LoVo-1 and K1 cells with high expression of ALDH1A3 were resistant to the focal adhesion kinase autophosphorylation inhibitor Y15, while cancer cells with low ALDH1A3 level showed high sensitivity to Y15 [46].